Personalized Medicine

SAN DIEGO — The future of ANCA-associated vasculitis management appears promising, as upcoming therapies will likely address current unmet needs, according to a speaker at the 2023 Congress of Clinical Rheumatology West.

DANA POINT, Calif. — In this Healio video exclusive, Fatima Cody Stanford, MD, MPA, MPH, MBA, discusses considerations clinicians must make regarding women with obesity.

PARK CITY, Utah — Five trends will shape treatment for allergic airway diseases in the years ahead, according to a keynote speaker.

M. Elaine Husni, MD, MPH, spoke with Healio about treatment and management options in psoriatic arthritis, including lifestyle changes. “We now have really embraced the concept of wellness strategies,” said Husni, vice chair of rheumatology and director of the Arthritis and Musculoskeletal Center and staff physician in the Orthopedic and Rheumatologic Institute at Cleveland Clinic, and assistant professor at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University.

Healio | Cardiology Today Editorial Board Member Jagmeet P. Singh, MD, DPhil, FACC, FHRS, and some of his patients were profoundly affected by the COVID-19 pandemic. That got him thinking about the sustainability of the health care system.

Physicians listen to the patient in front of us. We care for one patient at a time. There is inherent individualization in the patient interaction. Each story is unique. Each treatment plan is tailored.

Manpreet Kaur Singh, MD, MS, spoke with Healio about her presentation on personalized treatment selection for mood disorders using biotypes at this year’s NEI Congress.

BOSTON — Optimizing HF therapy is the best way to reduce disease morbidity and mortality and clinicians should consider personalizing and titrating guideline-directed medical therapy based on patient comorbidities, according to a speaker.

In this video, Christine M. Walko, PharmD, BCOP, FCCP, discussed four colorectal cancer presentations from ASCO Annual Meeting, including the phase 3 TRIPLETE study, phase 3 STRATEGIC-1 study, IMPROVE study and late-breaking PARADIGM trial.

In this video, Christine M. Walko, PharmD, BCOP, FCCP, discussed the importance of biomarker testing and the challenges involved.